Last reviewed · How we verify
CCR5 Tropic Drug Resistant HIV Infection
Approved treatments
- Selzentry · GSK
Selzentry works by blocking the CCR5 receptor on immune cells, preventing HIV from entering and infecting these cells. - Selzentry · Icahn School of Medicine at Mount Sinai
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- CCR5 Tropic Drug Resistant HIV Infection patent landscape — cliff calendar, originator estates, attackable patents
- CCR5 Tropic Drug Resistant HIV Infection treatment landscape brief
- CCR5 Tropic Drug Resistant HIV Infection treatment updates RSS
Frequently asked questions about CCR5 Tropic Drug Resistant HIV Infection
What drugs treat CCR5 Tropic Drug Resistant HIV Infection?
Tracked treatments include Selzentry.
What is the treatment for CCR5 Tropic Drug Resistant HIV Infection?
Standard treatment for CCR5 Tropic Drug Resistant HIV Infection includes Selzentry. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: CCR5 Tropic Drug Resistant HIV Infection patent cliff · CCR5 Tropic Drug Resistant HIV Infection CI report
- Treatment: Selzentry · GSK
- Treatment: Selzentry · Icahn School of Medicine at Mount Sinai
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing